MISTY LYKE: Open Payments
NPI 1821449018 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 32 payments from 12 companies in 2025. Trend: 2023 $560 · 2024 $490 · 2025 $791
Food & beverage: $691Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $181 |
| Procept Biorobotics Corporation | 1 | $153 |
| ABBVIE INC. | 3 | $84 |
| Astellas Pharma US Inc | 5 | $79 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Endo USA, Inc. | 2 | $59 |
| Sumitomo Pharma America, Inc. | 3 | $53 |
| Ferring Pharmaceuticals Inc. | 1 | $31 |
| Boston Scientific Corporation | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
Products named: ERLEADA, AQUABEAM ROBOTIC SYSTEM, BOTOX, Xtandi, PLUVICTO, ORGOVYX, ADSTILADRIN, EDEX.
Industry payments across FL — which companies pay providers there.
